These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 35331674)

  • 1. The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis.
    Silveira MAD; Bilodeau S; Greten TF; Wang XW; Trinchieri G
    Trends Cancer; 2022 Jul; 8(7):583-597. PubMed ID: 35331674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota influence tumor development and Alter interactions with the human immune system.
    Ge Y; Wang X; Guo Y; Yan J; Abuduwaili A; Aximujiang K; Yan J; Wu M
    J Exp Clin Cancer Res; 2021 Jan; 40(1):42. PubMed ID: 33494784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-Microbiome Interaction in Lung Cancer.
    Dong Q; Chen ES; Zhao C; Jin C
    Front Immunol; 2021; 12():679829. PubMed ID: 34108973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors.
    Kamiya T; Ohtani N
    Int Immunol; 2022 Sep; 34(9):467-474. PubMed ID: 35652367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases.
    Yang X; Lu D; Zhuo J; Lin Z; Yang M; Xu X
    Int J Biol Sci; 2020; 16(13):2357-2366. PubMed ID: 32760203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections.
    Ancona G; Alagna L; Lombardi A; Palomba E; Castelli V; Renisi G; Dondossola D; Iavarone M; Muscatello A; Gori A; Bandera A
    Infect Immun; 2021 Oct; 89(11):e0037621. PubMed ID: 34460287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut-liver axis in immune remodeling of hepatic cirrhosis.
    Guan H; Zhang X; Kuang M; Yu J
    Front Immunol; 2022; 13():946628. PubMed ID: 37408838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems to model the personalized aspects of microbiome health and gut dysbiosis.
    Matthewman C; Narin A; Huston H; Hopkins CE
    Mol Aspects Med; 2023 Jun; 91():101115. PubMed ID: 36104261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
    Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
    Front Immunol; 2020; 11():612202. PubMed ID: 33488618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
    Albillos A; de Gottardi A; Rescigno M
    J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota: A new piece in understanding hepatocarcinogenesis.
    Zhou A; Tang L; Zeng S; Lei Y; Yang S; Tang B
    Cancer Lett; 2020 Apr; 474():15-22. PubMed ID: 31917160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
    Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
    Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
    Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
    Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral-gut-circulatory axis: from homeostasis to colon cancer.
    Tortora SC; Agurto MG; Martello LA
    Front Cell Infect Microbiol; 2023; 13():1289452. PubMed ID: 38029267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of xenobiotic-induced gut microbiota dysbiosis: from correlation to mechanisms.
    Chi L; Tu P; Ru H; Lu K
    Gut Microbes; 2021; 13(1):1921912. PubMed ID: 34313531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.
    Wang M; Zhang L; Chang W; Zhang Y
    Front Immunol; 2022; 13():1096551. PubMed ID: 36726985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Faecal Microbiota and Small ncRNAs in Autism: Detection of miRNAs and piRNAs with Possible Implications in Host-Gut Microbiota Cross-Talk.
    Chiappori F; Cupaioli FA; Consiglio A; Di Nanni N; Mosca E; Licciulli VF; Mezzelani A
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
    Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota and viral hepatitis: State of the art of a complex matter.
    Milosevic I; Russo E; Vujovic A; Barac A; Stevanovic O; Gitto S; Amedei A
    World J Gastroenterol; 2021 Sep; 27(33):5488-5501. PubMed ID: 34588747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
    Jiang JW; Chen XH; Ren Z; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.